|
7MEQ
Crystal structure of human TMPRSS2 in complex with Nafamostat
Deposited 2021-04-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
109–492(384 aa)
|
Not recorded
|
GBS 4-carbamimidamidobenzoic acid × 1
UNX UNKNOWN LIGAND × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;291 K;30.0% (w/v) Jeffamine ED-2001 7.0, 0.1 M HEPES pH7.0
|
Resolution 1.95 Å
R-free 0.225
|
|
7XYD
Crystal structure of TMPRSS2 in complex with Nafamostat
Deposited 2022-06-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
109–254(146 aa)
Chain C
256–492(237 aa)
|
Mutation:Residues 250-255 SSRQSR were mutated to DDDDK
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CA CALCIUM ION × 1
GBS 4-carbamimidamidobenzoic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4;293 K;0.1M acetic acid/sodium acetate, pH 4.0, 20% w/v PEG 4000
|
Resolution 2.58 Å
R-free 0.248
|
|
7XYD
Crystal structure of TMPRSS2 in complex with Nafamostat
Deposited 2022-06-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
109–254(146 aa)
Chain D
256–492(237 aa)
|
Mutation:Residues 250-255 SSRQSR were mutated to DDDDK
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CA CALCIUM ION × 1
GBS 4-carbamimidamidobenzoic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4;293 K;0.1M acetic acid/sodium acetate, pH 4.0, 20% w/v PEG 4000
|
Resolution 2.58 Å
R-free 0.248
|
|
7Y0E
Crystal structure of TMPRSS2 in complex with Camostat
Deposited 2022-06-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
109–254(146 aa)
Chain C
256–492(237 aa)
|
Mutation:Residues 250-255 SSRQSR were replaced with DDDDK.
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CA CALCIUM ION × 1
GBS 4-carbamimidamidobenzoic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M acetic acid/sodium acetate, pH 5.0, 16% w/v PEG 8000
|
Resolution 2.39 Å
R-free 0.239
|
|
7Y0E
Crystal structure of TMPRSS2 in complex with Camostat
Deposited 2022-06-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
109–254(146 aa)
Chain D
256–492(237 aa)
|
Mutation:Residues 250-255 SSRQSR were replaced with DDDDK.
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CA CALCIUM ION × 1
GBS 4-carbamimidamidobenzoic acid × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M acetic acid/sodium acetate, pH 5.0, 16% w/v PEG 8000
|
Resolution 2.39 Å
R-free 0.239
|
|
7Y0F
Crystal structure of TMPRSS2 in complex with UK-371804
Deposited 2022-06-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
109–254(146 aa)
Chain C
256–492(237 aa)
|
Mutation:Residues 250-255 (SSRQSR) in the database have been replaced with DDDDK.
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CA CALCIUM ION × 1
I9V 2-[(1-carbamimidamido-4-chloranyl-isoquinolin-7-yl)sulfonylamino]-2-methyl-propanoic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M acetic acid/sodium acetate, pH 5.0, 16% w/v PEG 8000
|
Resolution 2.60 Å
R-free 0.237
|
|
7Y0F
Crystal structure of TMPRSS2 in complex with UK-371804
Deposited 2022-06-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
109–254(146 aa)
Chain D
256–492(237 aa)
|
Mutation:Residues 250-255 (SSRQSR) in the database have been replaced with DDDDK.
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CA CALCIUM ION × 1
I9V 2-[(1-carbamimidamido-4-chloranyl-isoquinolin-7-yl)sulfonylamino]-2-methyl-propanoic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M acetic acid/sodium acetate, pH 5.0, 16% w/v PEG 8000
|
Resolution 2.60 Å
R-free 0.237
|
|
8HD8
Crystal structure of TMPRSS2 in complex with 212-148
Deposited 2022-11-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
109–254(146 aa)
Chain C
256–492(237 aa)
|
Mutation:Residues 250-255 SSRQSR were replaced with DDDDK.
|
CA CALCIUM ION × 1
GBS 4-carbamimidamidobenzoic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M acetic acid/sodium acetate, pH 4.0, 20% w/v PEG 4000
|
Resolution 2.40 Å
R-free 0.218
|
|
8HD8
Crystal structure of TMPRSS2 in complex with 212-148
Deposited 2022-11-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
109–254(146 aa)
Chain D
256–492(237 aa)
|
Mutation:Residues 250-255 SSRQSR were replaced with DDDDK.
|
CA CALCIUM ION × 1
GBS 4-carbamimidamidobenzoic acid × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M acetic acid/sodium acetate, pH 4.0, 20% w/v PEG 4000
|
Resolution 2.40 Å
R-free 0.218
|
|
8JHZ
Cryo-EM structure of the TcsH-TMPRSS2 complex
Deposited 2023-05-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
106–492(387 aa)
|
Not recorded
|
ZN ZINC ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
|
Resolution 3.20 Å
|
|
8JI0
Cryo-EM structure of the TcsH-CROP in complex with TMPRSS2
Deposited 2023-05-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
106–492(387 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|
|
8S0L
Crystal structure of the TMPRSS2 zymogen in complex with the nanobody A07
Deposited 2024-02-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
107–492(386 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;20 %w/v PEG 3350, 0.05 M HEPES (pH 7.0), 1 %w/v Tryptone, 0.001 %w/v NaN3
|
Resolution 1.80 Å
R-free 0.215
|
|
8S0M
Crystal structure of the HKU1 receptor binding domain in complex with TMPRSS2 and the nanobody A01
Deposited 2024-02-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
107–492(386 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.35 M NaH2PO4, 0.65 M K2HPO4
|
Resolution 3.55 Å
R-free 0.221
|
|
8S0M
Crystal structure of the HKU1 receptor binding domain in complex with TMPRSS2 and the nanobody A01
Deposited 2024-02-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
107–492(386 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.35 M NaH2PO4, 0.65 M K2HPO4
|
Resolution 3.55 Å
R-free 0.221
|
|
8S0N
Crystal structure of the TMPRSS2 zymogen in complex with the nanobody A07
Deposited 2024-02-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
107–492(386 aa)
|
Mutation:S441A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;291 K;10 %w/v PEG 3000, 0.1 M imidazole (pH 8.0), 0.2 M lithium sulfate
|
Resolution 2.30 Å
R-free 0.246
|
|
8S0N
Crystal structure of the TMPRSS2 zymogen in complex with the nanobody A07
Deposited 2024-02-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
107–492(386 aa)
|
Mutation:S441A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;291 K;10 %w/v PEG 3000, 0.1 M imidazole (pH 8.0), 0.2 M lithium sulfate
|
Resolution 2.30 Å
R-free 0.246
|
|
8V04
High resolution TMPRSS2 structure following acylation by nafamostat
Deposited 2023-11-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
148–255(108 aa)
Chain B
256–492(237 aa)
Fragment:Peptidase S1 domain residues 256-492
|
Mutation:S251D, R252D, Q253D, S254D, R255K
|
EDO 1,2-ETHANEDIOL × 9
UNX UNKNOWN LIGAND × 1
GBS 4-carbamimidamidobenzoic acid × 1
CIT CITRIC ACID × 1
CA CALCIUM ION × 1
PG4 TETRAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;291 K;3 uL hanging drop (2:1 protein:precipitant) grown over precipitant solution containing 25%PEG4000, 0.2M ammonium sulfate, and 0.1M sodium acetate pH 4.6. Protein (10 mg/mL) was in a buffer containing 25 mM Tris pH 8.0, 75 mM NaCl, and 2 mM CaCl2
|
Resolution 1.58 Å
R-free 0.181
|
|
8V1F
TMPRSS2 complexed with the noncovalent inhibitor 6-amidino-2-napthol
Deposited 2023-11-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
148–255(108 aa)
Fragment:SRCR domain non-catalytic chain residues 148-254
Chain B
256–492(237 aa)
Fragment:Peptidase S1 domain residues 256-492
|
Mutation:S251D, R252D, Q253D, S254D, R255K
|
TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 3
UNX UNKNOWN LIGAND × 1
EDO 1,2-ETHANEDIOL × 12
7R8 6-oxidanylnaphthalene-2-carboximidamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;precipitant containing 20% PEG3350, 0.2 M dibasic ammonium citrate. Protein mixed 1uL:1uL protein:precipitant and set as 2 uL hanging drop on glass slides
|
Resolution 2.19 Å
R-free 0.223
|
|
8V1F
TMPRSS2 complexed with the noncovalent inhibitor 6-amidino-2-napthol
Deposited 2023-11-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
148–255(108 aa)
Fragment:SRCR domain non-catalytic chain residues 148-254
Chain D
256–492(237 aa)
Fragment:Peptidase S1 domain residues 256-492
|
Mutation:S251D, R252D, Q253D, S254D, R255K
|
TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 1
UNX UNKNOWN LIGAND × 2
EDO 1,2-ETHANEDIOL × 8
7R8 6-oxidanylnaphthalene-2-carboximidamide × 1
PEG DI(HYDROXYETHYL)ETHER × 1
CIT CITRIC ACID × 2
PG4 TETRAETHYLENE GLYCOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;precipitant containing 20% PEG3350, 0.2 M dibasic ammonium citrate. Protein mixed 1uL:1uL protein:precipitant and set as 2 uL hanging drop on glass slides
|
Resolution 2.19 Å
R-free 0.223
|
|
8VGT
Structure of the HKU1 RBD bound to the human TMPRSS2 receptor
Deposited 2023-12-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
109–492(384 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
8Y1E
3up-TM conformation of HKU1-B S protein after incubation of the receptor
Deposited 2024-01-24
|
Different construct
Different mutation/modification
Different oligomeric state
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
109–492(384 aa)
Chain E
109–492(384 aa)
Chain F
109–492(384 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 51
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å
|
|
8Y7X
Structure of HCoV-HKU1A spike in the functionally anchored-3up conformation with 3TMPRSS2
Deposited 2024-02-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain x
109–492(384 aa)
Chain y
109–492(384 aa)
Chain z
109–492(384 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 23
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.09 Å
|
|
8Y7Y
Local structure of HCoV-HKU1A spike in complex with TMPRSS2 and glycan
Deposited 2024-02-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain T
109–492(384 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
MJJ methyl 9-O-acetyl-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.24 Å
|
|
8Y87
Structure of HCoV-HKU1C spike in the functionally anchored-1up conformation with 1TMPRSS2
Deposited 2024-02-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain T
109–492(384 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 22
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.26 Å
|
|
8Y88
Structure of HCoV-HKU1C spike in the functionally anchored-2up conformation with 2TMPRSS2
Deposited 2024-02-06
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain I
109–492(384 aa)
Chain T
109–492(384 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.03 Å
|
|
8Y89
Structure of HCoV-HKU1C spike in the functionally anchored-3up conformation with 2TMPRSS2
Deposited 2024-02-06
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain G
109–492(384 aa)
Chain T
109–492(384 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 13
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.32 Å
|
|
8Y8A
Structure of HCoV-HKU1C spike in the functionally anchored-3up conformation with 3TMPRSS2
Deposited 2024-02-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain G
109–492(384 aa)
Chain H
109–492(384 aa)
Chain T
109–492(384 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 10
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.19 Å
|
|
8Y8B
Local structure of HCoV-HKU1C spike in complex with TMPRSS2 and glycan
Deposited 2024-02-06
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
109–492(384 aa)
Chain T
109–492(384 aa)
|
Not recorded
|
MJJ methyl 9-O-acetyl-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.01 Å
|
|
8YOY
Structure of HKU1A RBD with TMPRSS2
Deposited 2024-03-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
109–492(384 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.21 Å
|
|
8YQQ
Structure of HKU1B RBD with TMPRSS2
Deposited 2024-03-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
109–492(384 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.95 Å
|
|
9E83
TMPRSS2 crystal structure following acylation by UCSF_157
Deposited 2024-11-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
148–255(108 aa)
Chain B
256–492(237 aa)
Fragment:Peptidase S1 domain residues 256-492
|
Mutation:S251D/R252D/Q253D/S254D/R255K
|
CIT CITRIC ACID × 1
EDO 1,2-ETHANEDIOL × 3
VU4 4-(2-aminoethyl)benzoic acid × 1
UNX UNKNOWN LIGAND × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;291 K;3 uL hanging drop (2:1 protein:precipitant) grown over precipitant solution containing 25%PEG4000, 0.2M ammonium sulfate, and 0.1M sodium acetate pH 4.6. Protein (10 mg/mL) was in a buffer containing 25 mM Tris pH 8.0, 75 mM NaCl, and 2 mM CaCl2
|
Resolution 2.07 Å
R-free 0.260
|
|
9IZN
Crystal structure of HKU1A RBD bound to TMPRSS2
Deposited 2024-08-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
109–492(384 aa)
|
Mutation:R255Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;2% v/v Tacsimate pH 7.0, 5% v/v 2-Propanol, 0.1 M Imidazole (pH 7.0) and 8% w/v Polyethylene glycol 3350
|
Resolution 2.40 Å
R-free 0.261
|
|
9JCX
Crystal structure of the HCoV-HKU1 RBD and TMPRSS2
Deposited 2024-08-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
109–254(146 aa)
Chain C
256–492(237 aa)
|
Mutation:S250D,S251D,R252D,Q253D, S254K
Mutation:S441A
|
CA CALCIUM ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;0.2 M Tris pH 7.0, 0.2 M MgCl2, 10% (w/v) Polyethylene glycol 8,000
|
Resolution 2.75 Å
R-free 0.237
|
|
9JD0
Crystal structure of TMPRSS2 in complex with nanobody
Deposited 2024-08-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
109–254(146 aa)
Chain C
256–492(237 aa)
|
Mutation:S250D,S251D,R252D,Q253D, S254K
|
CA CALCIUM ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
GOL GLYCEROL × 1
MLI MALONATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;0.2 M sodium malonate pH 6.0, 10% (w/v) Polyethylene glycol 3,350
|
Resolution 2.00 Å
R-free 0.221
|
|
9JD0
Crystal structure of TMPRSS2 in complex with nanobody
Deposited 2024-08-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
109–254(146 aa)
Chain D
256–492(237 aa)
|
Mutation:S250D,S251D,R252D,Q253D, S254K
|
CA CALCIUM ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
MLI MALONATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;0.2 M sodium malonate pH 6.0, 10% (w/v) Polyethylene glycol 3,350
|
Resolution 2.00 Å
R-free 0.221
|
|
9JD1
Crystal structure of TMPRSS2 in complex with Fab
Deposited 2024-08-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
109–254(146 aa)
Chain D
256–492(237 aa)
|
Mutation:S250D,S251D,R252D,Q253D, S254K
|
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1
GOL GLYCEROL × 2
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;50 mM MES pH 5.6, 8.6% (w/v) Polyethylene glycol 4,000, 17.1% (v/v) Polyethylene glycol 600
|
Resolution 1.90 Å
R-free 0.223
|
|
9K3T
Cryo-EM structure of TMPRSS2 in complex with Fab fragments of 752 mAb and 2228 mAb
Deposited 2024-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
109–492(384 aa)
|
Mutation:250SSRQSR255 replaced with DDDDDK
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.15 Å
|
|
9OPQ
TMPRSS2 (S441A) bound to the HCoV-NL63 S2'region genetically fused to the HCoV-HKU1 RBD
Deposited 2025-05-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
110–492(383 aa)
|
Mutation:S441A
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å
|
|
9OPR
TMPRSS2 S441A in complex with the H1H7 Fab and anti-kappa light chain nanobody
Deposited 2025-05-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
110–492(383 aa)
|
Mutation:S441A
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
9U8G
Crystal structure of TMPRSS2 in complex with nanobody77_10
Deposited 2025-03-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
109–254(146 aa)
Chain B
256–492(237 aa)
|
Mutation:S250D,S251D,R252D,Q253D, S254K
|
CA CALCIUM ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;100 mM HEPES/ Sodium hydroxide pH 7.0, 10% w/v PEG 6000
|
Resolution 2.00 Å
R-free 0.230
|
|
9U8G
Crystal structure of TMPRSS2 in complex with nanobody77_10
Deposited 2025-03-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
109–254(146 aa)
Chain D
256–492(237 aa)
|
Mutation:S250D,S251D,R252D,Q253D, S254K
|
CA CALCIUM ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;100 mM HEPES/ Sodium hydroxide pH 7.0, 10% w/v PEG 6000
|
Resolution 2.00 Å
R-free 0.230
|
|
9Z3J
HCoV-NL63 S2' peptide bound to TMPRSS2 S441A (complexed with the H1H7 Fab and an anti-kappa-nanobody)
Deposited 2025-11-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
110–249(140 aa)
Chain B
256–492(237 aa)
|
Mutation:S441A
Mutation:S441A
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|